As a whooping cough epidemic spreads in France, supply tensions for macrolide antibiotics, essential for treatment, are increasing. The National Medicines Safety Agency (ANSM) is warning of the high consumption of these drugs and is anticipating measures to manage the situation.
Supply tensions for essential antibiotics in the treatment of whooping cough
The France is currently affected by a whooping cough epidemicleading to a significant increase in demand for antibiotics. The consumption of macrolidesoften prescribed against this disease, has increased sharply, affecting both pediatric and adult versions. Faced with this situation, the authorities have decided to strengthen their monitoring, and are considering strategies to mitigate the impact on the market, said Pierre-Olivier Farenq, director of the ANSM crisis center.
Distribution measures for winter
To prevent a disruption in supply, the National Medicines Safety Agency has asked laboratories to supply wholesale distributors as a priority in order to ensure equitable distribution. This reinforced monitoring, which also concerns amoxicillin and other seasonal treatments, is part of the agency’s plan for winter. Implemented last year, this aims to anticipate and respond to tensions during periods of high viral circulation.
> L’news continuously on Linfo.re
